| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193323 | Annals of Allergy, Asthma & Immunology | 2007 | 9 Pages |
Abstract
In this trial, up to 52 weeks of regular use of levalbuterol HFA MDI or racemic albuterol HFA MDI was well tolerated, and no deterioration of lung function was detected during the study period.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Daniel L. MD, Anthony MD, Robin J. MD, Michael MD, Kenneth MA, Merdad MD, PhD, Rudolf A. MD, William K. PhD,